News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Excessive IPFD ups risk of pancreatic diseases
10 May 2026
byStephen Padilla
Excessive intrahepatic fat deposition (IPFD) appears to contribute to an increased risk of major pancreatic disease, suggests a recent study, noting the potential benefits of IPFD reduction in preventing pancreatitis and pancreatic cancer.
10 May 2026

Seladelpar delivers improvements in cholestatic biomarkers, pruritus in PBC patients
09 May 2026
byStephen Padilla
Treatment with seladelpar for up to 2 years improves cholestatic biomarkers and pruritus in patients with primary biliary cholangitis (PBC), with no serious safety concerns noted with long-term use, as shown by interim results of the ASSURE study.
09 May 2026

Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
byStephen Padilla
The extended-release combination of naltrexone and bupropion (NB-ER) may be used as safe and effective treatment for weight reduction among individuals with overweight/obesity and mild to moderate symptoms of depression, suggests a study.
08 May 2026






